Heron Therapeutics (HRTX) has issued an update.
Ira Duarte has been appointed as the new principal accounting officer of Heron Therapeutics, Inc., set to take over from Lisa Peraza on March 29, 2024. Duarte’s background information is available from a previous SEC filing, with no arrangements or family ties influencing her selection. There are no financial conflicts of interest, and her compensation will remain unchanged in her new role.
For a thorough assessment of HRTX stock, go to TipRanks’ Stock Analysis page.
